Poseida Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Poseida Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2018 to Q4 2023.
  • Poseida Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $15.3M, a 29.4% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $15.3M +$3.47M +29.4% Dec 31, 2023 10-K 2024-03-07
Q4 2022 $11.8M +$2.31M +24.3% Dec 31, 2022 10-K 2024-03-07
Q4 2021 $9.49M +$4.04M +74% Dec 31, 2021 10-K 2024-03-07
Q4 2020 $5.46M +$2.99M +121% Dec 31, 2020 10-K 2023-03-09
Q4 2019 $2.47M +$1.72M +227% Dec 31, 2019 10-K 2022-03-10
Q4 2018 $755K Dec 31, 2018 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.